ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 762555 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 762555; 2) Community: the network communities that were significantly associated with the response to NSC 762555; 3) Molecule: the relationships between components within communities and NSC 762555; 4) MDR: the compounds that were significantly associated with the NSC 762555.

NSC Compound Enrichment Correlation
NSC 735036 6-[3-(2-Hydroxyethyl)-methylamino-1-propyl]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]iso quinoline Hydrochloride 0.0303322639291194 -0.1370023
NSC 735037 Camptothecin Derivative 0.0303322639291194 -0.11147782
NSC 736993 2-(naphthalen-2-yl)-1-(3,4,5-trimethoxyphenyl)-1H-imidazole 0.0303322639291194 -0.24166583
NSC 7390 Null 0.0303322639291194 -0.22190391
NSC 746058 Null 0.0303322639291194 -0.22187533
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0303322639291194 -0.15112178
NSC 755523 Null 0.0303322639291194 -0.17496146
NSC 757387 ACRIFLAVINIUM HYDROCHLORIDE 0.0303322639291194 0.0092317038
NSC 759630 LANATOSIDE C 0.0303322639291194 0.02339465
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0337307532806863 0.57962754
Total:75  Current:50    [First] [Prev] [Next] [Last]